stockportfolio.pro
Charles River Laboratories International, Inc. Revenue 2008–2025
Charles River Laboratories International, Inc. (CRL) annual revenue by fiscal year, computed from SEC filings. Compound growth +6.9%/yr over 17 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $4.02B | -0.9% |
| FY 2024 | $4.05B | -1.9% |
| FY 2023 | $4.13B | +3.9% |
| FY 2022 | $3.98B | +12.3% |
| FY 2021 | $3.54B | +21.1% |
| FY 2020 | $2.92B | +11.5% |
| FY 2019 | $2.62B | +15.7% |
| FY 2018 | $2.27B | +22.0% |
| FY 2017 | $1.86B | +10.5% |
| FY 2016 | $1.68B | +23.3% |
| FY 2015 | $1.36B | +5.1% |
| FY 2014 | $1.30B | +11.3% |
| FY 2013 | $1.17B | +3.2% |
| FY 2012 | $1.13B | -1.1% |
| FY 2011 | $1.14B | +0.8% |
| FY 2010 | $1.13B | -3.3% |
| FY 2009 | $1.17B | -9.5% |
| FY 2008 | $1.30B | — |
Source: Charles River Laboratories International, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Charles River Laboratories International, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCharles River Laboratories International, Inc. — frequently asked questions
What is Charles River Laboratories International, Inc.'s revenue?
Charles River Laboratories International, Inc. (CRL) reported revenue of $4.02B for fiscal year 2025, per its SEC filings.
How has Charles River Laboratories International, Inc.'s revenue changed over time?
Between fiscal 2008 and 2025, CRL's revenue grew at roughly 6.9% per year (compound annual rate), from $1.30B to $4.02B.
Where does this data come from?
Figures are computed from Charles River Laboratories International, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.